Yuan, W., Xu, W., Li, Y., Jiang, W., Li, Y., Huang, Q., . . . Wu, J. (2019). TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription. Cell Death Dis.
Chicago Style CitationYuan, Weiwei, et al. "TAZ Sensitizes EGFR Wild-type Non-small-cell Lung Cancer to Gefitinib By Promoting Amphiregulin Transcription." Cell Death Dis 2019.
Cita MLAYuan, Weiwei, et al. "TAZ Sensitizes EGFR Wild-type Non-small-cell Lung Cancer to Gefitinib By Promoting Amphiregulin Transcription." Cell Death Dis 2019.
Atenció: Aquestes cites poden no estar 100% correctes.